| Literature DB >> 36135662 |
Balanagouda Patil1,2, Shankarappa Sridhara3, Hanumappa Narayanaswamy1, Vinayaka Hegde2, Ajay Kumar Mishra4.
Abstract
Fruit rot disease (FRD) in arecanut has appeared in most of the arecanut growing regions of India in the last few decades. A few comprehensive studies on the management of FRD under field conditions have examined various treatment combinations for disease control and yield response analysis. This study aimed to compare the control efficiencies and yield responses of treatments applied over multiple locations and compute the probable returns of investment (ROIs) for treatment costs. Data were gathered from 21 field trials conducted across five main arecanut growing regions of India in the period 2012-2019. The collected data were subjected to analysis with a multivariate (network) meta-analytical model, following standard statistical protocols. The quantitative, synthesized data were evaluated for the estimated effects of disease pressure (DPLow ≤ 35% of FRDInc in the treatments > DPHigh), mean disease control efficiencies (treatment mean, C), and yield responses (R) corresponding to the tested treatments. Based on disease control efficacy, the evaluated treatments were grouped into three efficacy groups (EGs): higher EGs were observed for the Bordeaux mixture (C, 81.94%) and its stabilized formulation (C, 74.99%), Metalaxyl + Mancozeb (C, 70.66%), while lower EGs were observed in plots treated with Biofight (C, 29.91%), Biopot (C, 25.66%), and Suraksha (C, 29.74%) and intermediate EGs were observed in plots to which microbial consortia (bio-agents) had been applied. Disease pressure acted as a significant moderator variable, influencing yield response and gain. At DPLow, the Bordeaux fungicide mixture (102%, 22% of increased yield) and Metalaxyl + Mancozeb (77.5%, +15.5%) exhibited higher yield responses, with absolute arecanut yield gains of 916.5 kg ha-1 and 884 kg ha-1, while, under DPHigh, Fosetyl-AL (819.6 kg ha-1) showed a yield response of 90.5%. To ensure maximum yield sustainability, arecanut growers should focus on the spraying of fungicides (a mixture of different active ingredients or formulations or products) as a preventative measure, followed by treating palms with either soil microbial consortia or commercial formulations of organic fungicides.Entities:
Keywords: Areca catechu; control efficiency; fruit rot disease; network meta-analysis; yield response
Year: 2022 PMID: 36135662 PMCID: PMC9503749 DOI: 10.3390/jof8090937
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Location map of field trials conducted during the six growing seasons from 2012 to 2019 across the main Indian arecanut growing regions.
Information about the evaluated treatments against fruit rot disease (FRD) with multi-environment profiles.
| Treatments/Fungicides | Dose (%) | Type of Fungicide | Management Principle | Type of Application | Agri-System |
|---|---|---|---|---|---|
| Bordeaux Mixture | 1.0–5.0 | Contact | Chemical | Foliar | Organic |
| Copper oxychloride | 0.20 | Contact | Chemical | Foliar | Organic |
| Metalaxyl + Mancozeb | 0.25 | Combi | Chemical | Foliar | Inorganic |
| Potassium Phosphonate | 0.3–0.6 | Systemic | Chemical | Foliar | Phosphonates |
| Cymoxanil + Mancozeb | 0.30 | Combi | Chemical | Foliar | Inorganic |
| Bordeaux Mixture (Stabilized) | 1.00 | Contact | Chemical | Foliar | Organic |
| Fenamidone + Mancozeb | 0.30 | Combi | Chemical | Foliar | Inorganic |
| Fosetyl-Al | 0.30 | Systemic | Chemical | Soil application amended with fertilizers | Phosphonates |
| Blue Bordo | 1.0–5.0 | Contact | Chemical | Foliar | Organic |
| Polyethylene cover | -- | -- | Mechanical | Bunch Cover | Conventional |
| Biofight | 0.5 | Systemic | Bio-product | Foliar | Organic |
| Biopot | 0.5 | Systemic | Bio-product | Foliar | Organic |
| Suraksha | 0.5 | Systemic | Bio-product | Foliar | Organic |
| 200 g/palm | -- | Bio-control | Soil application of microbial consortia | Biological | |
| 200 g/palm | -- | Bio-control | Soil application of microbial consortia | Biological | |
| 200 g/palm | -- | Bio-control | Soil application of microbial consortia | Biological | |
| Bm + Th + PF consortia | 200 g/palm | -- | Bio-control | Soil application of microbial consortia | Biological |
Descriptions of the locations of the experimental trials conducted in different provinces against FRD in arecanut.
| District/Province | Experimental Locations | The Year the Trial Was Conducted |
|---|---|---|
| Uttara Kannada (North Canara) | Sirsi | 2010 |
| Uttara Kannada (North Canara) | Bilaghi, Siddapura | 2013 |
| Shivamogga | Varadamula | 2014, 2015, 2016 |
| Shivamogga | Sagara | 2014, 2015, 2016 |
| Shivamogga | Tuppooru | 2014, 2015, 2016 |
| Shivamogga | Kouti | 2014, 2015, 2016 |
| Thirthahalli | Wodeyala | 2014, 2015, 2016 |
| Thirthahalli | Bobbi | 2014, 2015, 2016 |
| Sagara | Manchale | 2015, 2016, 2017 |
| Sagara | Koluru | 2015, 2016, 2017 |
| Sagara | Melige | 2015, 2016, 2017 |
| Raigad | Shriwardhan | 2016 |
| Raigad | Diveagar | 2016 |
| Raigad | Nagoli | 2016 |
| Raigad | Chaul | 2016 |
| Thirthahalli | Agumbe | 2016 |
| Thirthahalli | Agumbe | 2017 |
| Thirthahalli | Agumbe | 2018 |
Figure 2Treatment mean values (points) of FRD incidence and arecanut yield (Kg/Palm). AACHECK = untreated control, with treatments tested at different concentrations. Th = Trichoderma harzianum; Ps = Pseudomonas fluorescence; Bm = Bacillus megatarium.
Figure 3Categorization of trials based on trial mean values for disease pressures and yield levels among the treatments conducted with multi-environment profiles from 2012 to 2019. Th = Trichoderma harzianum; Ps = Pseudomonas fluorescence; Bm = Bacillus megatarium.
Estimated response rate for FRD (DPHigh > 35%) for each treatment compared to the untreated check, as determined via the network meta-analytical model. Percentages of control efficiency and corresponding model statistics are represented.
| Treatments a | Effect Size c | Control Efficiency (%) d | ||||||
|---|---|---|---|---|---|---|---|---|
| K b |
| SE | 95% CI |
| P |
| 95% CI | |
| Intercept | - | 4.245 | 0.054 | 4.13: 4.35 | 78.58 | 0.0001 | - | -- |
| Bordeaux mixture (1%) | 21 | −1.711 | 0.228 | −2.16: −1.26 | −7.47 | 0.0001 | 81.94 | 71.72: 88.46 |
| Copper oxychloride (0.25%) | 18 | −0.938 | 0.111 | −1.15: −0.72 | −8.45 | 0.0001 | 60.87 | 51.37: 68.52 |
| Metalaxyl + Mancozeb (0.2%) | 21 | −1.229 | 0.241 | −1.70: −0.75 | −5.09 | 0.0001 | 70.76 | 53.07: 81.78 |
| Biofight (0.5%) | 12 | −0.355 | 0.052 | −0.45: −0.25 | −6.73 | 0.0001 | 29.91 | 22.27: 36.80 |
| Biopot (0.5%) | 12 | −0.296 | 0.057 | −0.40: −0.18 | −5.17 | 0.0001 | 25.66 | 16.83: 33.55 |
| Bordeaux mixture (1%)–Stabilized | 16 | −0.386 | 0.082 | −1.54: −1.22 | −16.87 | 0.0001 | 74.99 | 70.62: 78.71 |
| Cymoxanil + Mancozeb (0.2%) | 16 | −0.782 | 0.075 | −0.92: −0.63 | −10.41 | 0.0001 | 54.25 | 47.00: 60.51 |
| Suraksha (0.5%) | 12 | −0.353 | 0.053 | −0.45: −0.24 | −6.62 | 0.0001 | 29.74 | |
The network meta-analysis model fitted the data collected from the field trials carried out under multi-location conditions in India. a Active ingredients of treatments used against FRD in arecanut under field conditions. b The number of trials selected for each specific treatment with untreated controls. c Mean logarithmic rate ratio (L) for the average effect of each treatment on FRD compared to the untreated check standard error (SE) of L and 95% confidence interval (CI) containing L; Z (standard normal) statistic from the network meta-analytical model; p = probability value (level of significance). d Average percentage of control efficiency (C) and 95% CI containing C; Test for Residual Heterogeneity; QE (df = 52) = 7689.7531, p-value < 0.0001; Test of Moderators (coefficients 2:9); QM (df = 8) = 358.1598, p-value < 0.0001.
Figure 4Overall mean control efficiency (%) of evaluated treatments against FRD was estimated by multivariate meta-analysis. Horizontal bars represent 95% confidence intervals; points indicate the differences in control efficiency.
Estimated response rates for FRD (DPLow > 35%) for each treatment compared to the untreated check as determined via the network meta-analytical model. Percentages of control efficiency and corresponding model statistics are represented.
| Treatments a | Effect Size c | Control Efficiency (%) d | ||||||
|---|---|---|---|---|---|---|---|---|
| K b |
| SE | 95% CI |
| P |
| 95% CI | |
| Intercept | - | 3.126 | 0.060 | 3.08: 3.24 | 52.079 | 0.0001 | - | -- |
| Bordeaux mixture (1%) | 21 | −1.024 | 0.086 | −1.19: −0.85 | −11.830 | 0.0001 | 64.10 | 57.46: 69.70 |
| 9 | −0.413 | 0.042 | −0.49: −0.33 | −9.754 | 0.0001 | 33.84 | 28.11: 39.11 | |
| Fenamidone + Mancozeb (0.3%) | 9 | −1.051 | 0.062 | −1.17: −0.92 | −16.804 | 0.0001 | 65.05 | 60.48: 69.07 |
| 9 | −0.340 | 0.042 | −0.42: −0.25 | −8.084 | 0.0001 | 28.88 | 22.75: 34.52 | |
| Th, Ps, Bm + microbial consortium | 9 | −0.632 | 0.059 | −0.74: −0.51 | −10.604 | 0.0001 | 46.87 | 40.29: 52.74 |
| 9 | −0.257 | 0.044 | −0.34: −0.17 | −5.771 | 0.0001 | 22.69 | 15.63: 29.61 | |
| Blue Bordo (1.5%) | 6 | −0.409 | 0.078 | −0.56: −0.25 | −5.225 | 0.0001 | 33.58 | 22.56: 43.03 |
| Blue Bordo (1%) | 6 | −0.480 | 0.044 | −0.70: −0.25 | −4.249 | 0.0001 | 38.17 | 22.82: 50.46 |
| Blue Bordo (2.5%) | 6 | −0.413 | 0.078 | −0.56: −0.26 | −5.402 | 0.0001 | 33.88 | 23.18: 43.10 |
| Blue Bordo (2%) | 6 | −0.309 | 0.113 | −0.45: −0.16 | −4.226 | 0.0001 | 26.61 | 15.25: 36.42 |
| Bordeaux mixture (1.5%) | 9 | −0.438 | 0.086 | −0.60: −0.26 | −5.053 | 0.0001 | 35.50 | 23.54: 43.59 |
| Bordeaux mixture (2.5%) | 9 | −0.356 | 0.071 | −0.49: −0.21 | −5.016 | 0.0001 | 30.00 | 19.53: 39.10 |
| Bordeaux mixture (2%) | 9 | −0.425 | 0.075 | −0.57: −0.27 | −5.671 | 0.0001 | 34.64 | 24.31: 43.60 |
The network meta-analysis model fitted the data collected from the field trials carried out under multi-location conditions in India. a Active ingredients of treatments used against FRD in arecanut under field conditions. b The number of trials selected for each specific treatment with untreated controls. c Mean logarithmic rate ratio (L) for the average effect of each treatment on FRD compared to untreated checks; standard error (SE) of L and 95% confidence interval (CI) containing L; Z (standard normal) statistic from the network meta-analytical model; p = probability value (level of significance). d Average percentage of control efficiency (C) and 95% CI containing C; Test for Residual Heterogeneity; QE (df = 59) = 7739.0720, p-value < 0.0001; Test of Moderators (coefficients 2:14); QM (df = 9) = 432.0348, p-value < 0.0001.
Average arecanut yield differences (D) among treated plots and untreated controls (low yield level) estimated through the network meta-analysis with related model parameters and computed yield response (%) for the evaluated treatments for FRD (DPHigh > 35%).
| Treatments a | Effect Size c | Yield Response (%) d | ||||||
|---|---|---|---|---|---|---|---|---|
| K b |
| SE | 95% CI |
| P |
| 95% CI | |
| Intercept | - | −0.043 | 0.106 | −0.25: 0.16 | −0.407 | 0.6838 | - | -- |
| Bordeaux mixture (1%) | 10 | 0.480 | 0.083 | 0.31: 0.64 | 5.781 | 0.0001 | 61.70 | 37.40: 90.30 |
| 6 | 0.197 | 0.103 | −0.05: 0.39 | 1.913 | 0.0557 | 21.80 | −0.48: 49.10 | |
| Fenamidone + Mancozeb (0.3%) | 6 | 0.328 | 0.100 | 0.13: 0.54 | 3.269 | 0.0011 | 38.90 | 14.10: 69.20 |
| 6 | 0.057 | 0.111 | −0.16: 0.27 | 0.518 | 0.6042 | 5.93 | −14.80: 31.70 | |
| Th, Ps, Bm + microbial consortium | 6 | 0.198 | 0.111 | −0.01: 0.41 | 1.782 | 0.0747 | 21.90 | −1.69: 51.60 |
| 6 | 0.088 | 0.102 | −0.11: 0.28 | 0.860 | 0.3897 | 9.23 | −10.70: 33.60 | |
| Fosetyl AL (0.3%)–Konkan briquettes | 4 | 0.633 | 0.087 | 0.46: 0.80 | 7.279 | 0.0001 | 88.30 | 58.80: 123.0 |
| Fosetyl AL (0.3%)–root feeding | 4 | 0.567 | 0.088 | 0.39: 0.74 | 6.408 | 0.0001 | 76.50 | 48.30: 110.0 |
| Fosetyl AL (0.3%)–Urea briquettes | 4 | 0.646 | 0.087 | 0.47: 0.81 | 7.370 | 0.0001 | 90.80 | 60.70: 127.0 |
The network meta-analysis model fitted the data collected from the field trials carried out under multi-location conditions in India. a Active ingredients of the evaluated treatments for FRD in arecanut. b The number of trials selected for each specific treatment with untreated controls. c Mean yield differences (D, kg/palm) for each treatment corresponding to untreated checks; standard error (SE) of D and 95% confidence interval (CI) around D; Z (standard normal) statistic from the network meta-analytical model; p = probability value (level of significance). d Average yield response (R) computed by back-transformation of estimated FRD incidence and 95% CI (lower and upper limits) containing R; Test for Residual Heterogeneity; QE (df = 52) = 63.7404, p-value = 0.1274; Test of Moderators (coefficients 2:10); QM (df = 9) = 194.2997, p-value < 0.0001.
Average arecanut yield differences (D) among treated and untreated controls (high yield levels), as estimated through the network meta-analysis, with related model parameters and computed yield responses (%) for the evaluated treatments for FRD (DPLow ≤ 35%).
| Treatments a | Effect Size c | Yield Response (%) d | ||||||
|---|---|---|---|---|---|---|---|---|
| K b |
| SE | 95% CI |
| P |
| 95% CI | |
| Bordeaux mixture (1%) | 8 | 0.705 | 0.135 | 0.44: 0.96 | 5.222 | 0.0001 | 102.0 | 55.40: 164.0 |
| Copper oxychloride (0.25%) | 5 | 0.462 | 0.171 | 0.12: 0.79 | 2.700 | 0.0069 | 58.80 | 13.50: 122.0 |
| Metalaxyl + Mancozeb (0.2%) | 5 | 0.533 | 0.150 | 0.23: 0.82 | 3.551 | 0.0004 | 70.40 | 27.0: 129.0 |
| Biofight (0.5%) | 5 | 0.140 | 0.166 | −0.18: 0.46 | 0.839 | 0.4012 | 15.00 | −17.10: 59.50 |
| Biopot (0.5%) | 5 | 0.020 | 0.176 | −0.36: 0.32 | −0.117 | 0.9062 | −2.05 | −30.50: 38.30 |
| Bordeaux mixture (1%)–Stabilized | 5 | 0.505 | 0.171 | 0.16: 0.84 | 2.946 | 0.0032 | 65.80 | 18.40: 132.0 |
| Cymoxanil + Mancozeb (0.2%) | 5 | 0.390 | 0.174 | 0.04: 0.73 | 2.240 | 0.0250 | 47.80 | 5.01: 108.0 |
| Suraksha (0.5%) | 5 | 0.073 | 0.169 | −0.25: 0.40 | 0.432 | 0.6651 | 7.60 | −22.80: 49.90 |
| Blue Bordo (1.5%) | 3 | 0.291 | 0.061 | 0.17: 0.41 | 4.742 | 0.0001 | 33.80 | 16.60: 50.90 |
| Blue Bordo (1%) | 3 | 0.205 | 0.041 | 0.12: 0.28 | 4.924 | 0.0001 | 22.80 | 13.20: 33.30 |
| Blue Bordo (2.5%) | 3 | 0.201 | 0.042 | 0.11: 0.28 | 4.750 | 0.0001 | 22.30 | 12.50: 32.80 |
| Blue Bordo (2%) | 3 | 0.250 | 0.043 | 0.16: 0.33 | 5.814 | 0.0001 | 28.50 | 18.10: 39.80 |
| Bordeaux mixture (1.5%) | 3 | 0.571 | 0.112 | 0.35: 0.79 | 5.105 | 0.0001 | 77.10 | 42.20: 121.0 |
| Bordeaux mixture (2.5%) | 3 | 0.346 | 0.053 | 0.24: 0.44 | 6.529 | 0.0001 | 41.30 | 27.40: 56.80 |
| Bordeaux mixture (2%) | 3 | 0.490 | 0.105 | 0.28: 0.69 | 4.657 | 0.0001 | 63.30 | 32.90: 101.0 |
The network meta-analysis model fitted the data collected from the field trials carried out under multi-location conditions in India. a Active ingredients of the evaluated treatments for FRD in arecanut. b The number of trials selected for each specific treatment and untreated controls. c Mean yield difference (D, kg/palm) for each treatment corresponding to the untreated check; standard error (SE) of D and 95% confidence interval (CI) around D; Z (standard normal) statistic from the network meta-analytical model; p = probability value (level of significance). d Average yield response (R) computed by back-transformation of estimated FRD incidence and 95% CI (lower and upper limits) containing R; Test for Residual Heterogeneity; QE (df = 56) = 522.6497, p-value < 0.0001; Test of Moderators (coefficients 2:16); QM (df = 15) = 404.3491, p-value < 0.0001.
Figure 5Yield differences (D, points) and 95% confidence intervals (horizontal lines) for each evaluated treatment used to control FRD in arecanut at both disease baseline classes (low ≤ 35%, high > 35%). These values were estimated by fitting the network meta-analysis model in R software.